Ropeginterferon

DRUG3 trials

Sponsors

St. Olavs Hospital, Dong-Wook Kim, Brigham and Women's Hospital

Conditions

CML (Chronic Myelogenous Leukemia)Chronic Myeloid LeukemiaJAK2 Mutation

Phase 1

Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis

RecruitingNCT07249840

Brigham and Women's HospitalJAK2 Mutation

Start: 2026-07-24End: 2030-08-01Target: 12Updated: 2026-07-28

Phase 2

Long-acting Low Dose Ropeginterferon for Chronic Myeloid Leukemia Treated With Bosutinib From Diagnosis

CompletedNCT03831776

St. Olavs HospitalChronic Myeloid Leukemia

Start: 2019-03-25End: 2024-12-31Updated: 2025-06-08

Phase 4

Ropeginterferon for Treatment Free Remission

CompletedNCT07105319

Dong-Wook KimCML (Chronic Myelogenous Leukemia)

Start: 2021-11-30End: 2025-07-30Updated: 2025-08-22